News

Press Releases
General
Newsletters
Publication

May 2nd, 2021

The GOG Foundation, Inc. | ACOG TV Video
Read More arrow icon

March 31st, 2021

GOG Partners Connection Quarterly Newsletter - March 2021
Read More arrow icon

March 15th, 2021

Phase 3 Trial of Libtayo® (cemiplimab) Monotherapy in Advanced Cervical Cancer Stopped Early for Positive Result on Overall Survival
Read More arrow icon

March 2nd, 2021

Antibody Drug Conjugates as a New Class of Agents in Treating Recurrent Ovarian Cancer
Read More arrow icon

March 2nd, 2021

GOG-P - Improving Care of Women’s Cancer - TiP of the Iceberg, An Independent Satellite Symposium during The SGO Annual Virtual Meeting on Women’s Cancer® - March 24th
Read More arrow icon

February 3rd, 2021

A discussion with Dr. Previs & Dr. Tewari on actively accruing GYN Clinical Trials
Read More arrow icon

January 27th, 2021

Advances in The Systemic Treatment of Cervical Cancer Through Clinical Trials
Read More arrow icon

January 5th, 2021

GOG Foundation Virtual “Dinner” Meeting
Read More arrow icon

December 17th, 2020

A Message From Larry J. Copeland, MD President, GOG Foundation, Inc.
Read More arrow icon

December 16th, 2020

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Combination Demonstrated Statistically Significant Improvement in Overall Survival, Progression-Free Survival and Objective Response Rate Versus Chemotherapy in Patients With Advanced Endometrial Cancer Following Prior Systemic Therapy in Phase 3 Study
Read More arrow icon
Showing posts 41 - 50 of 56.